Phase I study of gemcitabine and vinorelbine in nonsmall cell lung cancer (NSCLC)-elderly patients

被引：0
|
作者：
Santomaggio, C
Portalone, L
Seebacher, C
Bazzicalupo, F
Soresi, E
机构：
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
136
引用
收藏
页码：81 / 81
页数：1
相关论文
共 50 条
  • [41] Phase II Study of Gemcitabine and Vinorelbine as a Combination Chemotherapy for the Second-Line Treatment of Nonsmall Cell Lung Carcinoma
    Lee, EunJoo
    Ha, EunSil
    Park, SangHoon
    Hur, GyuYoung
    Jung, KiHwan
    Jeong, HyeCheol
    Lee, SungYong
    Kim, JeHyeong
    Lee, SangYeub
    Sin, Chol
    Shim, JaeJeong
    In, KwangHo
    Kang, KyungHo
    Yoo, Sehwa
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2005, 59 (05) : 510 - 516
  • [42] Gemcitabine plus vinorelbine (GEMVIN) in the treatment of advanced non-small cell lung cancer (NSCLC). Sequential phase I and phase II trials
    Cigolari, S
    Gridelli, C
    Frontini, L
    Gulisano, M
    Robbiati, SF
    Farris, A
    Clerici, M
    Castiglione, F
    Piazza, E
    Ianniello, GP
    Perrone, F
    ANNALS OF ONCOLOGY, 1998, 9 : 87 - 87
  • [43] Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial
    Roy S. Herbst
    Cathleen Lynch
    Michael Vasconcelles
    Beverly A. Teicher
    Gary Strauss
    Anthony Elias
    Ian Anderson
    Patrick Zacarola
    Nam H. Dang
    Traci Leong
    Ravi Salgia
    Arthur T. Skarin
    Cancer Chemotherapy and Pharmacology, 2001, 48 : 151 - 159
  • [44] Gemcitabine(GEM) in advanced non small cell lung cancer (NSCLC) of elderly. A phase II study
    Pasquini, E
    Tassinari, D
    Nicolini, M
    Gianni, L
    Oliverio, G
    Tononi, A
    Papi, M
    Drudi, G
    Panzini, I
    Ravaioll, A
    ANNALS OF ONCOLOGY, 1998, 9 : 32 - 32
  • [45] Chemotherapy in elderly patients with nonsmall cell lung cancer
    Veluswamy, Rajwanth R.
    Levy, Benjamin
    Wisnivesky, Juan P.
    CURRENT OPINION IN PULMONARY MEDICINE, 2016, 22 (04) : 336 - 343
  • [46] Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial
    Herbst, RS
    Lynch, C
    Vasconcelles, M
    Teicher, BA
    Strauss, G
    Elias, A
    Anderson, I
    Zacarola, P
    Dang, NH
    Leong, T
    Salgia, R
    Skarin, AT
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 48 (02) : 151 - 159
  • [47] A phase II study with vinorelbine, gemcitabine and cisplatin in the treatment of patients with stage IIIb-IV non-small cell lung cancer (NSCLC)
    Ginopoulos, P
    Mastronikolis, NS
    Giannios, J
    Karana, A
    Siabi, V
    Karvelas, F
    Rathossis, S
    Apostolopoulos, N
    Mastorakou, A
    LUNG CANCER, 1999, 23 (01) : 31 - 37
  • [48] A phase II study of gemcitabine and vinorelbine combination followed by sequential gefitinib monotherapy in elderly patients with non-small cell lung cancer
    Kasahara, K.
    Kita, T.
    Shibata, K.
    Nishi, K.
    Ishiura, Y.
    Araya, T.
    Tambo, Y.
    Sakai, A.
    Kimura, H.
    Fujimura, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [49] Randomized phase II study of cisplatin/vinorelbine vs cisplatin/gemcitabine vs vinorelbine/gemcitabine in patients with advanced non-small cell lung cancer
    Tsai, CM
    Perng, RP
    Wang, GS
    Chen, YM
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 78 - 78
  • [50] Gemcitabine and vinorelbine, a phase I study in patients with advanced malignancies
    Chaouche, M
    Delord, JP
    Raymond, E
    Vayre, L
    Ducreux, M
    Ruffle, P
    Rodier, JM
    Armand, JP
    ANNALS OF ONCOLOGY, 1998, 9 : 165 - 165
12345